<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-119939</identifier>
<setSpec>0365-6691</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Treatment of conjunctival melanoma</dc:title>
<dc:description xml:lang="en">Clinical case: The cases of an 86 year-old woman and a 61 year-old man with conjunctival pigmented tumors are presented. An excisional biopsy, conjunctival cryotherapy and amniotic membrane grafts were performed in both cases, along with the application of mitomycin-C in the postoperative period. The histology study confirmed the clinical suspicion of melanoma. Tolerance was good during the follow-up with no signs of recurrence in the last 12 and 6 months, respectively. Discussion: The recommended treatment for conjunctival melanoma is surgical removal with adjunctive therapies such as cryotherapy or topical mitomycin-C. This is a well tolerated therapy and effective for preventing recurrences in the short-medium term (AU)</dc:description>
<dc:creator>Parra Rodríguez, T</dc:creator>
<dc:creator>Baamonde Arbaiza, B</dc:creator>
<dc:creator>Salazar Méndez, R</dc:creator>
<dc:creator>Roz Martín, P. de la</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Casos clínico: Mujer de 86 años y varón de 61 años con sendas tumoraciones conjuntivales pigmentadas. En ambos casos se realiza biopsia escisional, crioterapia en conjuntiva, recubrimiento con membrana amniótica y aplicación de mitomicina C (MMC) en el pos-operatorio. El estudio histológico confirmó la sospecha clínica de melanoma. Durante el seguimiento la tolerancia ha sido buena, sin signos de recurrencia al cabo de 12 y 6 meses, respectivamente. Discusión: El tratamiento de elección en el melanoma conjuntival es la resección quirúrgica, asociada a tratamientos adyuvantes como la crioterapia o la MMC tópica. Es una terapia bien tolerada y eficaz en la prevención de recurrencias a corto-medio plazo (AU)</dc:description>
<dc:source>Arch Soc Esp Oftalmol;89(2): 82-84, feb. 2014. ilus</dc:source>
<dc:identifier>ibc-119939</dc:identifier>
<dc:title xml:lang="es">Tratamiento del melanoma conjuntival</dc:title>
<dc:subject>^d8714^s22067</dc:subject>
<dc:subject>^d31536^s22045</dc:subject>
<dc:subject>^d3254^s22067</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d19059</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d665^s22070</dc:subject>
<dc:type>article</dc:type>
<dc:date>201402</dc:date>
</metadata>
</record>
</ibecs-document>
